New York State Common Retirement Fund Voyager Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $74.9 Billion
- Q3 2025
A detailed history of New York State Common Retirement Fund transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 12,732 shares of VYGR stock, worth $50,928. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,732
Previous 12,732
-0.0%
Holding current value
$50,928
Previous $39,000
48.72%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding VYGR
# of Institutions
125Shares Held
29.9MCall Options Held
121KPut Options Held
16.2K-
Black Rock Inc. New York, NY5.31MShares$21.3 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.2MShares$16.8 Million0.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.25MShares$13 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.29MShares$9.17 Million0.0% of portfolio
-
Vestal Point Capital, LP New York, NY1.48MShares$5.9 Million0.31% of portfolio
About Voyager Therapeutics, Inc.
- Ticker VYGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,647,600
- Market Cap $155M
- Description
- Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...